Lemtrada

Lemtrada is a medicine that is used to treat adults with relapsing-remitting multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves as well as the nerves themselves. ‘Relapsing-remitting’ means that the patient has attacks (relapses) between periods with few or no symptoms (remissions). Lemtrada is used for patients with: - disease that is highly active, even though they have been treated with a disease-modifying therapy; - rapidly worsening, severe disease, who have had 2 or more relapses in one year and whose brain scans show certain brain lesions. Lemtrada contains the active substance alemtuzumab.